Blood biomarker has potential in stroke; Biomarkers could support food health claims;

> A blood biomarker could differentiate between two causes of acute stroke, helping physicians to apply the best treatment as early as possible, according to a presentation at the American Stroke Association meeting. Press release

> Governments, industry and academia are collaborating to find biomarkers for 'optimal health' to support nutrition-related health claims. Article

> A potential monoclonal antibody-based biomarker test picked up 85% of early stage pancreatic cancers. Abstract

> Health Canada cleared Miraculins' PreVu skin cholesterol test as a biomarker for heart disease. Press release

> Horizon Diagnostics has signed an agreement to work with UK NEQAS to develop genetically defined reference standards for lung cancer biomarkers. Press release

> Combining hormonal, functional and genetic biomarkers could be the best route to personalizing controlled ovarian stimulation in fertility treatment. Paper (.pdf)

> Genetically modified mice may play a role in identifying new biomarkers. Abstract

> The Biomarker Factory has announced a request for proposals for the identification and validation of biomarkers that will have an impact in clinical practice in human healthcare. Announcement

> Three Dutch companies have joined forces to develop a biomarker assay for Alzheimer's disease. Press release

> Proxy Life Science is collaborating with NutraClinical on clinical studies of its Proxysome biomarker-based 'virtual biopsy' technology. Press release

> University of Maryland is seeking partners for a breath biomarkers discovery system. Technology

And Finally... A new MarketsandMarkets report suggests the global biomarkers market will be worth $25.79 billion by 2016. Press release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.